Clinical SupplementPowered by HealixAI • HSA/FSA Eligible
Saccharomyces Boulardii CNCM I-745
Clinically studied probiotic yeast Saccharomyces boulardii (10 Billion CFU) + MOS to protect intestinal tight junctions during and after antibiotic therapy.
Clinically Reviewed by HealixAI Board-Certified Physicians•Gastroenterology & Microbiome Formulary•HCPCS / Code: LMN-213D
HSA / FSA Eligible • Save ~30%
Enlarge1/2 ViewsEnlarge Studio View
Medical Dispensary
Saccharomyces Boulardii CNCM I-745 (10 Billion CFU Antibiotic & Gut Shield)
Chart Indication: K58.9 (Irritable bowel syndrome without diarrhea)
Antibiotic Microbiome Stewardship: High-potency Lactobacillus & Bifidobacterium protocol (dosed 2 hours apart from antibiotics) to prevent antibiotic-associated dysbiosis.
$41.00$54.00~$28.70 w/ HSA·FSA
In Stock • Direct Dispatch via Medical Dispensary
Compare stores:
Qualifying Health Goals (HSA/FSA)
- Noninfective gastroenteritis and colitis, unspecified
- Irritable bowel syndrome with diarrhea (IBS-D)
- Enterocolitis due to Clostridium difficile
Clinical Guidance & Safety
ACG & WGO Probiotic Clinical Guideline — Saccharomyces boulardii is naturally resistant to antibacterial antibiotics and carries Level 1A evidence for preventing antibiotic-associated diarrhea and C. difficile recurrence.
Medication check recommended if taking: central venous catheter, severe neutropenia.
Want dosing & safety tailored to your lab results and medications?
Sync your health records or ask Healix Medical Intelligence by voice on this page.
